{
  "id": 6750,
  "url": "https://nnemf.org/research/6750-mechanisms-and-therapeutic-effectiveness-of-pulsed-electromagnetic-field",
  "title": "Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology",
  "authors": [
    "Maria Vadalà",
    "Julio Cesar Morales‐Medina",
    "Annamaria Vallelunga",
    "Beniamino Palmieri",
    "Carmen Laurino",
    "Tommaso Iannitti"
  ],
  "journal": "Cancer Med.",
  "year": "2016",
  "doi": "10.1002/cam4.861",
  "pmid": "27748048",
  "abstract": "Cancer is one of the most common causes of death worldwide. Available treatments are associated with numerous side effects and only a low percentage of patients achieve complete remission. Therefore, there is a strong need for new therapeutic strategies. In this regard, pulsed electromagnetic field (PEMF) therapy presents several potential advantages including non‐invasiveness, safety, lack of toxicity for non‐cancerous cells, and the possibility of being combined with other available therapies. Indeed, PEMF stimulation has already been used in the context of various cancer types including skin, breast, prostate, hepatocellular, lung, ovarian, pancreatic, bladder, thyroid, and colon cancer in vitro and in vivo. At present, only limited application of PEMF in cancer has been documented in humans. In this article, we review the experimental and clinical evidence of PEMF therapy discussing future perspectives in its use in oncology.",
  "effect": "unclear",
  "evidence": "insufficient",
  "extraction": {
    "studyType": "review",
    "studyTypeLabel": "Review",
    "effectDirection": "unclear",
    "evidenceLabel": "Insufficient",
    "population": "—",
    "sampleSize": "—",
    "exposure": "pulsed electromagnetic field (PEMF) therapy",
    "confidencePct": "66",
    "peerReviewed": "yes",
    "mainFindings": "The article reviews experimental (in vitro and in vivo) and limited human evidence on pulsed electromagnetic field (PEMF) therapy across multiple cancer types, discussing potential advantages and future perspectives. It notes that application in humans has been limited.",
    "outcomes": [
      "therapeutic effectiveness in oncology",
      "mechanisms of action"
    ],
    "limitations": [
      "No specific PEMF exposure parameters (e.g.",
      "frequency",
      "intensity",
      "duration) provided in the abstract",
      "Human evidence described as limited"
    ],
    "keywords": [
      "pulsed electromagnetic field",
      "PEMF",
      "oncology",
      "cancer therapy",
      "in vitro",
      "in vivo",
      "clinical evidence"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"review\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": \"pulsed electromagnetic field (PEMF) therapy\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": null,\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"therapeutic effectiveness in oncology\",\n    \"mechanisms of action\"\n  ],\n  \"main_findings\": \"The article reviews experimental (in vitro and in vivo) and limited human evidence on pulsed electromagnetic field (PEMF) therapy across multiple cancer types, discussing potential advantages and future perspectives. It notes that application in humans has been limited.\",\n  \"effect_direction\": \"unclear\",\n  \"limitations\": [\n    \"No specific PEMF exposure parameters (e.g., frequency, intensity, duration) provided in the abstract\",\n    \"Human evidence described as limited\"\n  ],\n  \"evidence_strength\": \"insufficient\",\n  \"confidence\": 0.66,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"pulsed electromagnetic field\",\n    \"PEMF\",\n    \"oncology\",\n    \"cancer therapy\",\n    \"in vitro\",\n    \"in vivo\",\n    \"clinical evidence\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5119968/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=6750",
  "updated": "2026-02-26 20:17:46"
}